Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Tablet Dissolution Testing

Posted on By

SOP for Tablet Dissolution Testing

Procedure for Tablet Dissolution Testing

1) Purpose

The purpose of this SOP is to outline the procedure for testing the dissolution of tablets to ensure consistent release of the active pharmaceutical ingredient (API) over a specified time period.

2) Scope

This SOP applies to all tablet batches produced within the manufacturing facility.

3) Responsibilities

Quality Control (QC) Department: Responsible for conducting dissolution testing and ensuring compliance with this SOP.
Production Department: Responsible for providing tablet samples for testing and maintaining process parameters.

4) Procedure

4.1 Sampling:
    4.1.1 Collect a representative sample of tablets from different locations within a batch according to the sampling plan.
    4.1.2 Ensure the sample size is adequate (e.g., 12 tablets) to obtain a uniform representation.

See also  SOP for Angle of Repose Testing

4.2 Equipment Preparation:
    4.2.1 Set up the dissolution apparatus (e.g., USP apparatus) as per the manufacturer’s instructions.
    4.2.2 Ensure the apparatus is clean and calibrated.

4.3 Dissolution Testing Procedure:
    4.3.1 Fill each dissolution vessel with the specified dissolution medium (e.g., pH 6.8 phosphate buffer).
    4.3.2 Set the apparatus to the specified rotation speed (e.g., 50 rpm) and temperature (e.g., 37°C).
    4.3.3 Place one tablet in each vessel.
    4.3.4 Withdraw samples at specified time intervals (e.g., 15, 30, 45, and 60 minutes).
    4.3.5 Analyze the samples for API

content using a suitable analytical method (e.g., UV spectrophotometry).
    4.3.6 Calculate the percentage of API released over time.

See also  SOP for Adhesion Testing in Transdermal Patches

4.4 Acceptance Criteria:
    4.4.1 The tablet batch is acceptable if the dissolution profile meets the specified criteria (e.g., at least 80% of API released within 45 minutes).

4.5 Documentation:
    4.5.1 Document all results, dissolution profiles, and calculations in the Tablet Dissolution Test Record.
    4.5.2 Review and approve the documentation by QC Manager.

5) Abbreviations, if any

QC: Quality Control
API: Active Pharmaceutical Ingredient

6) Documents, if any

Tablet Dissolution Test Record
Calibration Record for Dissolution Apparatus
Sampling Plan Document

7) Reference, if any

USP <711> – Dissolution
21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals

8) SOP Version

Version 1.0

See also  SOP for Clarity and Opalescence Testing of Liquids
In-Process Control Tags:Blend uniformity testing SOP, Bulk density testing SOP, Capsule content uniformity SOP, Capsule disintegration testing SOP, Capsule dissolution testing SOP, Capsule weight variation SOP, Clarity and opalescence testing of liquids SOP, Endotoxin testing in injectable products SOP, Flowability testing of powders SOP, Granulation size distribution SOP, Moisture content determination in granules SOP, Osmolality testing SOP, Particulate matter testing in liquids SOP, pH measurement of solutions SOP, Pyrogen testing SOP, Specific gravity testing of liquids SOP, Sterility testing SOP, Tablet disintegration testing SOP, Tablet dissolution testing SOP, Tablet friability testing SOP, Tablet hardness testing SOP, Tablet thickness measurement SOP, Tablet weight variation SOP, Uniformity of dosage units SOP, Viscosity testing of liquids SOP

Post navigation

Previous Post: SOP for Sealing Integrity Check: Ensuring That the Capsules Are Properly Sealed to Prevent Leakage and Maintain Product Integrity
Next Post: SOP for Taste and Odor Evaluation: Sensory Evaluation to Confirm That Capsules Do Not Have Objectionable Taste or Odor

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version